MEMPHIS, Tenn.--(BUSINESS WIRE)--GTx, Inc. (Nasdaq: GTXI) announced today the appointment of Ronald A. Morton, Jr., M.D., F.A.C.S. as Chief Medical Officer.
“Ron Morton’s appointment as Chief Medical Officer further strengthens GTx’s management team, and he will provide outstanding medical leadership as we execute our commercialization plans for ACAPODENE and Ostarine,” said Mitchell S. Steiner, M.D., Chief Executive Officer of GTx. “Dr. Morton is an excellent fit for our company.”
